Jenkins, Tyler W.
Fitzgerald, Jacquelyn Elise
Park, Jieun
Wilson, Addison M.
Berry, Kristy L.
Wong, Keith S.
Houry, Walid A.
Lee, Irene
Maksimenko, Andrey V.
Panizzi, Peter R.
Maxuitenko, Yulia Y.
Loop, Matthew Shane
Mitra, Amit K.
Kisselev, Alexei F.
Funding for this research was provided by:
National Cancer Institute (5R01CA212223, 5R01CA212223, 5R01CA212223)
Canadian Institutes of Health Research (PJT-173345, PJT-173345)
Article History
Received: 3 January 2025
Accepted: 7 May 2025
First Online: 19 May 2025
Declarations
:
: Alexei F. Kisselev is the Founder and Chief Scientific Officer of InhiProt, LLC; other authors do not report any conflicts.